Literature DB >> 11852949

Measuring quality of life of patients of traumatic brain injury.

J A DePalma1.   

Abstract

Quality of life (QOL) is recognized as an important indicator of health care and the patient's ability to cope with illness, treatment, and recuperation. Issues that need to be addressed in any proposed QOL research include a clear definition of QOL, a sound rationale for the choice of a measurement instrument, and the value of qualitative data. Measuring QOL in a patient population that has experienced traumatic brain injury (TBI) raises special concerns associated with the physical, behavioral, and cognitive limitations inherent with the specific TBI population. These pertinent issues are discussed with a focus that should be helpful for persons planning QOL projects and those reading and critiquing related literature. A study conducted by the author with patients with severe trauma injury will be used as an example of the impact of these issues on an actual project.

Entities:  

Mesh:

Year:  2001        PMID: 11852949     DOI: 10.1097/00002727-200102000-00004

Source DB:  PubMed          Journal:  Crit Care Nurs Q        ISSN: 0887-9303


  3 in total

1.  An instrument to assess mental patients' capacity to appraise and report subjective quality of life.

Authors:  Josephine G W S Wong; Erik P T Cheung; Eric Y H Chen; Raymond C K Chan; C W Law; Molly S M Lo; K F Leung; Cindy L K Lam
Journal:  Qual Life Res       Date:  2005-04       Impact factor: 4.147

2.  Role of sertraline in posttraumatic brain injury depression and quality-of-life in TBI.

Authors:  Ahmed Ansari; Akhilesh Jain; Achal Sharma; R S Mittal; I D Gupta
Journal:  Asian J Neurosurg       Date:  2014 Oct-Dec

3.  Quantification of relevance of quality of life assessment for patients with cognitive impairment: the suitability indices.

Authors:  Karine Baumstarck; Mohamed Boucekine; Laurent Boyer; Valérie Aghababian; Nathalie Parola; Françoise Reuter; Anderson Loundou; Christophe Lançon; Jean Pelletier; Pascal Auquier
Journal:  BMC Neurol       Date:  2014-04-08       Impact factor: 2.474

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.